Clinical Division of Fish Medicine, University of Veterinary Medicine, Veterinärplatz 1, 1210 Vienna, Austria; Department of Pathology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.
Department of Pathology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.
Res Vet Sci. 2018 Aug;119:196-204. doi: 10.1016/j.rvsc.2018.06.019. Epub 2018 Jun 21.
The rise of bacterial resistance to antibiotics is one of the great challenges of our age. One of the strategies to limit the development of antibiotics resistance is the investigation of alternative antimicrobials. As silver nanoparticles demonstrated a potent bactericidal activity in vitro, the aim of this study was to evaluate the in vivo antibacterial activity of silver nanoparticles against Aeromonas salmonicida subsp. salmonicida. Rainbow trout (n = 120) were divided into four groups of 30 fish each. First group was challenged with A. salmonicida (Positive control), the second group was challenged with A. salmonicida and exposed to silver nanoparticles by immersion for three hours (100 μg/L), the third group was challenged with A. salmonicida and intraperitoneally injected with silver nanoparticles (17 μg/mL) and the fourth group was sham-treated and served as a negative control group. At the 7th day post challenge, histopathology of the positive control group revealed the presence of bacterial aggregates in tissues with degenerative and necrotic changes, while at the 35th day post challenge, only liver necrosis persisted. Silver nanoparticles-treated and negative control groups did not show any clinical signs, mortalities or histopathological alterations and they were tested negative for A. salmonicida. The immersion in silver nanoparticles did not result in detectable residues of silver in the muscles 35 days after treatment. These findings demonstrate the antibacterial properties of silver nanoparticles against A. salmonicida infection. Therefore, they could be used for development of antibacterial agents in aquaculture.
细菌对抗生素的耐药性上升是我们这个时代面临的重大挑战之一。限制抗生素耐药性发展的策略之一是研究替代抗菌药物。由于纳米银颗粒在体外具有很强的杀菌活性,本研究旨在评估纳米银颗粒对嗜水气单胞菌亚种嗜水气单胞菌的体内抗菌活性。虹鳟鱼(n=120)分为 4 组,每组 30 条鱼。第一组用嗜水气单胞菌攻毒(阳性对照组),第二组用嗜水气单胞菌攻毒,并用纳米银颗粒浸泡 3 小时(100μg/L),第三组用嗜水气单胞菌攻毒,并用纳米银颗粒腹腔注射(17μg/mL),第四组为假处理组,作为阴性对照组。攻毒后第 7 天,阳性对照组的组织病理学显示组织中有细菌聚集,伴有退行性和坏死性变化,而攻毒后第 35 天,仅肝脏坏死持续存在。纳米银颗粒处理组和阴性对照组均未出现临床症状、死亡或组织病理学改变,且未检出嗜水气单胞菌。攻毒后 35 天,浸泡纳米银颗粒后肌肉中未检测到可检出的银残留。这些发现表明纳米银颗粒对嗜水气单胞菌感染具有抗菌特性。因此,它们可用于水产养殖中抗菌剂的开发。